Global Interventional Neurology Market Outlook to 2020
Due to changing lifestyle and unhealthy dietary habits, a number of chronic diseases are affecting the masses across the globe. Some of the prominent disorders like obesity, diabetes, cardiovascular diseases and neurological ailments directly or indirectly lead to decline in the productivity of the working population, ultimately hampering the profitability of businesses. Therefore, increasing epidemiology of the diseases require effective treatment options. Although, conventional treatments have been successfully serving the patients for most of the diseases, yet these causes immense mental and physical pressure both on the part of surgeons and patients. Moreover, increasing healthcare expenditures along with changing consumers’ needs is generating significant demand for additional therapies. One such popular technique is interventional neurology. This technique provides a cost effective alternative for traditional neurosurgery.
According to RNCOS new release, “Global Interventional Neurology Market Outlook to 2020”, the industry is expanding at a fast pace. The study has been done comprehensively including factors affecting growth, latest innovations, market segmentation and competitive landscape.
The global market for interventional neurology was worth US$ 1.6 Billion in 2014. Embolyzing products (coils and systems) accounted for the largest share of the market in 2014, followed by Catheters. The report provides the current market and future forecast of different interventional neurology products. Moreover, the report also includes the detailed analysis of the report based on geography. According to the report, developed markets including those of the US, Germany, France, Italy, and the UK holds the major share in the market. However, the Asia Pacific region is slated to witness the highest growth in the forecasted period. The growth of the Asia Pacific market is driven by improving healthcare facilities and increasing government investment in this region.
Further, prudent analysis has been done on the competitor’s part, where three major players grab 70% of the global market by revenue. Stryker, Covidien, Terumo, and Johnson & Johnson are the key influencers with their products covering all the categories. New releases, collaborations and extending distribution networks are few important factors for their dominance.
Towards the end, RNCOS has suggested some recommendations to boost the interventional neurology market in the coming future. On the whole, the research contains exhaustive information that will help clients in formulating market strategies and assessing opportunity areas in the neurovascular devices industry.
According to RNCOS new release, “Global Interventional Neurology Market Outlook to 2020”, the industry is expanding at a fast pace. The study has been done comprehensively including factors affecting growth, latest innovations, market segmentation and competitive landscape.
The global market for interventional neurology was worth US$ 1.6 Billion in 2014. Embolyzing products (coils and systems) accounted for the largest share of the market in 2014, followed by Catheters. The report provides the current market and future forecast of different interventional neurology products. Moreover, the report also includes the detailed analysis of the report based on geography. According to the report, developed markets including those of the US, Germany, France, Italy, and the UK holds the major share in the market. However, the Asia Pacific region is slated to witness the highest growth in the forecasted period. The growth of the Asia Pacific market is driven by improving healthcare facilities and increasing government investment in this region.
Further, prudent analysis has been done on the competitor’s part, where three major players grab 70% of the global market by revenue. Stryker, Covidien, Terumo, and Johnson & Johnson are the key influencers with their products covering all the categories. New releases, collaborations and extending distribution networks are few important factors for their dominance.
Towards the end, RNCOS has suggested some recommendations to boost the interventional neurology market in the coming future. On the whole, the research contains exhaustive information that will help clients in formulating market strategies and assessing opportunity areas in the neurovascular devices industry.
1. ANALYST VIEW
2. RESEARCH METHODOLOGY
3. INTERVENTIONAL NEUROLOGY - AN INTRODUCTION
3.1 Techniques Involved in Interventional Neurology
3.1.1 Neurothrombectomy
3.1.2 Cerebral Angiography
3.1.3 Stenting technique
3.1.4 Coiling Procedure
4. DRIVERS & CHALLENGES
4.1 Drivers
4.1.1 Rising Healthcare Expenditure
4.1.2 Growing Geriatric Population
4.1.3 Rapidly Rising Cerebrovascular Diseases
4.1.4 Advantages Over Conventional Surgery
4.2 Challenges
4.2.1 High Cost of Interventional Neurovascular Devices
4.2.2 Low Awareness
5. INTERVENTIONAL NEUROLOGY MARKET OVERVIEW
6. MARKET SEGMENTATION
6.1 By Products
6.2 By Geography
7. TRENDS & DEVELOPMENTS
7.1 Interventional Neurology Benefiting Paralytic Patients
7.2 Market Rewarded with New Launches
8. COMPETITIVE ASSESSMENT
8.1 Market Share of Key Players
8.2 Company Profiles
8.2.1 Stryker Corporation
8.2.2 Covidien (A Wholly Owned Subsidiary of Medtronic Inc.)
8.2.3 Johnson & Johnson
8.2.4 Terumo Inc
9. RECOMMENDATIONS
2. RESEARCH METHODOLOGY
3. INTERVENTIONAL NEUROLOGY - AN INTRODUCTION
3.1 Techniques Involved in Interventional Neurology
3.1.1 Neurothrombectomy
3.1.2 Cerebral Angiography
3.1.3 Stenting technique
3.1.4 Coiling Procedure
4. DRIVERS & CHALLENGES
4.1 Drivers
4.1.1 Rising Healthcare Expenditure
4.1.2 Growing Geriatric Population
4.1.3 Rapidly Rising Cerebrovascular Diseases
4.1.4 Advantages Over Conventional Surgery
4.2 Challenges
4.2.1 High Cost of Interventional Neurovascular Devices
4.2.2 Low Awareness
5. INTERVENTIONAL NEUROLOGY MARKET OVERVIEW
6. MARKET SEGMENTATION
6.1 By Products
6.2 By Geography
7. TRENDS & DEVELOPMENTS
7.1 Interventional Neurology Benefiting Paralytic Patients
7.2 Market Rewarded with New Launches
8. COMPETITIVE ASSESSMENT
8.1 Market Share of Key Players
8.2 Company Profiles
8.2.1 Stryker Corporation
8.2.2 Covidien (A Wholly Owned Subsidiary of Medtronic Inc.)
8.2.3 Johnson & Johnson
8.2.4 Terumo Inc
9. RECOMMENDATIONS
LIST OF FIGURES:
Figure 5-1: Global - Interventional Neurology Market (Billion US$), 2014-2020
Figure 6-1: Global - Interventional Neurology Market by Products (%), 2014
Figure 6-2: Global - Embolizing Products Market for Interventional Neurology (Million US$), 2014 & 2020
Figure 6-3: Global - Cathetors Market for Interventional Neurology (Million US$), 2014 & 2020
Figure 6-4: Global - Stents Market for Interventional Neurology (Million US$), 2014 & 2020
Figure 6-5: Global - Other Instruments Market for Interventional Neurology (Million US$), 2014 & 2020
Figure 6-6: Global - Interventional Neurology Market by Geography (%), 2014
Figure 6-7: US - Interventional Neurology Market (Million US$), 2014 & 2020
Figure 6-8: Europe - Interventional Neurology Market (Million US$), 2014 & 2020
Figure 6-9: Asia-Pacific - Interventional Neurology Market (Million US$), 2014 & 2020
Figure 6-10: RoW - Interventional Neurology Market (Million US$), 2014 & 2020
Figure 8-1: Share of Major Players in Interventional Neurology Market (%), 2014
Figure 8-2: Stryker - Breakup of Revenue by Geography (%), 2014
Figure 8-3: Covidien - Breakup of Revenue by Geography (%), 2014
Figure 8-4: J&J - Breakup of Revenue by Geography (%), 2014
Figure 8-5: Terumo Inc - Breakup of Cardiac & Vascular Segment Revenue by Geography (%), 2014
Figure 5-1: Global - Interventional Neurology Market (Billion US$), 2014-2020
Figure 6-1: Global - Interventional Neurology Market by Products (%), 2014
Figure 6-2: Global - Embolizing Products Market for Interventional Neurology (Million US$), 2014 & 2020
Figure 6-3: Global - Cathetors Market for Interventional Neurology (Million US$), 2014 & 2020
Figure 6-4: Global - Stents Market for Interventional Neurology (Million US$), 2014 & 2020
Figure 6-5: Global - Other Instruments Market for Interventional Neurology (Million US$), 2014 & 2020
Figure 6-6: Global - Interventional Neurology Market by Geography (%), 2014
Figure 6-7: US - Interventional Neurology Market (Million US$), 2014 & 2020
Figure 6-8: Europe - Interventional Neurology Market (Million US$), 2014 & 2020
Figure 6-9: Asia-Pacific - Interventional Neurology Market (Million US$), 2014 & 2020
Figure 6-10: RoW - Interventional Neurology Market (Million US$), 2014 & 2020
Figure 8-1: Share of Major Players in Interventional Neurology Market (%), 2014
Figure 8-2: Stryker - Breakup of Revenue by Geography (%), 2014
Figure 8-3: Covidien - Breakup of Revenue by Geography (%), 2014
Figure 8-4: J&J - Breakup of Revenue by Geography (%), 2014
Figure 8-5: Terumo Inc - Breakup of Cardiac & Vascular Segment Revenue by Geography (%), 2014
LIST OF TABLES:
Table 7-1: New Devices Launched in Global Interventional Neurology Market, 2013-2015
Table 8-1: Stryker - Revenue by Business Segments (Million US$), 2013 & 2014
Table 8-2: Covidien - Revenue by Business Segments (Million US$), 2013 & 2014
Table 8-3: J&J - Revenue by Business Segments (Million US$), 2013 & 2014
Table 8-4: Terumo Inc - Revenue by Business Segments (Billion US$), 2013 & 2014
Table 7-1: New Devices Launched in Global Interventional Neurology Market, 2013-2015
Table 8-1: Stryker - Revenue by Business Segments (Million US$), 2013 & 2014
Table 8-2: Covidien - Revenue by Business Segments (Million US$), 2013 & 2014
Table 8-3: J&J - Revenue by Business Segments (Million US$), 2013 & 2014
Table 8-4: Terumo Inc - Revenue by Business Segments (Billion US$), 2013 & 2014
